methazolamide has been researched along with Muscular Dystrophy, Duchenne in 1 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Muscular Dystrophy, Duchenne: An X-linked recessive muscle disease caused by an inability to synthesize DYSTROPHIN, which is involved with maintaining the integrity of the sarcolemma. Muscle fibers undergo a process that features degeneration and regeneration. Clinical manifestations include proximal weakness in the first few years of life, pseudohypertrophy, cardiomyopathy (see MYOCARDIAL DISEASES), and an increased incidence of impaired mentation. Becker muscular dystrophy is a closely related condition featuring a later onset of disease (usually adolescence) and a slowly progressive course. (Adams et al., Principles of Neurology, 6th ed, p1415)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giacomotto, J | 1 |
| Brouilly, N | 1 |
| Walter, L | 1 |
| Mariol, MC | 1 |
| Berger, J | 1 |
| Ségalat, L | 1 |
| Becker, TS | 1 |
| Currie, PD | 1 |
| Gieseler, K | 1 |
1 other study available for methazolamide and Muscular Dystrophy, Duchenne
| Article | Year |
|---|---|
Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy.
Topics: Animals; Animals, Genetically Modified; Binding Sites; Caenorhabditis elegans; Caenorhabditis elegan | 2013 |